Business Wire

EDGE

21.2.2021 17:10:04 CET | Business Wire | Press release

Share
EDGE Unveils First UAE-made Family of Smart Loitering Munitions at IDEX 2021

EDGE , an advanced technology group for defence and beyond, today launches its first family of multirotor loitering munitions, the QX range. In addition, Shadow 50 and Shadow 25, Rash 2 gliding munition kit, as well as new variants of the RW24 range – all designed and manufactured in the company’s first year of operations – were unveiled on the first day of the International Defence Exhibition and Conference (IDEX 2021), that is underway at the Abu Dhabi National Exhibition Centre until 25 February.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210221005030/en/

The unveiling of the Class-1 electric unmanned aerial vehicles (UAVs) took place at the EDGE pavilion in the presence of His Excellency Faisal Al Bannai, CEO and Managing Director of EDGE and Ali Al Yafei, CEO of ADASI.

His Excellency Faisal Al Bannai, CEO & Managing Director, EDGE, said: “Right now, drone technology is revolutionising our world with the full potential of unmanned and autonomous capabilities still to be further explored – not just in the military sector, but the commercial sector too.”

He added: “Through launching the first UAE-made family of smart loitering drones, EDGE marks a significant milestone as a key technology enabler and in boosting the country’s autonomous capabilities and AI integration. With the future increasingly relying on unmanned systems that provide a higher degree of tactical flexibility, we have invested extensively to fast-track R&D investments in these domains, bringing related products to market with speed.”

The QX family of loitering munitions comprises four products: QX-1, a micro-UAV, QX-2, a mini-UAV, QX-3, a small UAV, and QX-4, which features an impressive vertical take-off and landing (VTOL) fixed wing. The precision-guided systems use sophisticated AI algorithms to target and strike, boasting an accuracy of 1 m CEP (circular error probable) – with an aim similar to laser guided munitions. Built to launch in any environment or terrain, the entire QX family of UAVs are lightweight, man portable, and comprise VTOL capabilities.

The second range of loitering munitions consists of Shadow 50 and Shadow 25. As the name implies, Shadow 50 can carry a payload of 50kg – exactly double its counterpart. Shadow 25 is a high-speed system equipped with a jet engine and boasts a short reaction time. Delivering high precision strike against fixed targets and advanced guidance capabilities, these UAVs leverage Global Navigation Satellite Systems (GNSS) and can fly using video navigation systems in GPS denied Environment.

Also launched on Day 1 of IDEX, the Rash 2 is a fixed-wing guidance kit for mortars and other in-house designed payloads, capable of gliding in flight and directing munitions to ground targets, available in different sizes to accommodate varying payload capacity, range, and endurance. ADASI has secured AED 55 million contract to supply Rash 2 to the UAE Armed Forces, marking the first order of the newly launched product.

Three new additions to the RW-24 range were also launched in time for IDEX 2021. The newly unveiled RW-24 Seeker is equipped with a thermal automatic seeker that enable greater accuracy of engagement of moving targets and increased functionality within GPS-denied environments.

The RW-24 Extended Warhead and RW-24 Extended Range variants increase the payload capacity from 8 kg to 13 kg, enabling the drone to carry additional fuel or to increase the size of the warhead.

EDGE is an advanced technology group that ranks among the top 25 military suppliers in the world.

About EDGE

EDGE is an advanced technology group established to develop agile, bold and disruptive solutions for defence and beyond. Enabling a secure future, it is dedicated to bringing innovative technologies and services to market with greater speed and efficiency. Consolidating over 25 entities and employing more than 13,000 brilliant minds, it offers expertise across five core clusters: Platforms & Systems, Missiles & Weapons, Cyber Defence, Electronic Warfare & Intelligence and Mission Support. Headquartered in Abu Dhabi, United Arab Emirates, EDGE is a catalyst for change – set to revolutionise the industry and change its fundamentals.

*Source: AETOSWire

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release

Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye